Gail Whitman, MD
Dermatology · Stratford, CTNPI 1043288061
Payments from drug & device makers
Across 413 payments — averaging $19.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$794
- Pfizer$590
- Sun Pharmaceutical Industries Inc.$411
- Galderma Laboratories, L.p.$398
- Dermavant Sciences, Inc.$388
- plus $4K from 28 others
What the payments were for
- Speaking & faculty fees$1,27916%
- Food & beverage$6,92984%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $1,759 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 44 | $794 |
| Pfizer | 38 | $590 |
| Sun Pharmaceutical Industries Inc. | 19 | $411 |
| Galderma Laboratories, L.p. | 26 | $398 |
| Dermavant Sciences, Inc. | 39 | $388 |
| Johnson & Johnson | 21 | $373 |
| Mayne Pharma Commercial LLC | 19 | $336 |
| Amgen | 18 | $335 |
| Incyte Corporation | 14 | $323 |
| Regeneron Healthcare Solutions, Inc. | 13 | $306 |
| LEO Pharma Inc. | 19 | $279 |
| Dermira, Inc. | 8 | $241 |
| Sanofi | 9 | $234 |
| Journey Medical Corporation | 9 | $180 |
| Organon | 12 | $152 |
| Lilly USA, LLC | 6 | $145 |
| Arcutis Biotherapeutics, Inc. | 8 | $137 |
| VYNE Pharmaceuticals Inc. | 15 | $137 |
| Almirall LLC | 8 | $133 |
| EPI Health, LLC | 5 | $117 |
| Novartis | 5 | $108 |
| Encore Dermatology Inc. | 3 | $61 |
| Biofrontera Inc. | 2 | $45 |
| Aclaris Therapeutics, Inc. | 2 | $43 |
| Verrica Pharmaceuticals Inc. | 2 | $37 |
| Genentech USA, Inc. | 1 | $34 |
| Glenmark Therapeutics Inc. | 1 | $21 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $19 |
| Sebela Pharmaceuticals Inc. | 1 | $18 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Strata Skin Sciences, Inc. | 1 | $13 |
| Bristol Myers Squibb | 1 | $13 |
How this compares
$8,208 in reported general payments places this provider in the 70th percentile of 222 dermatology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 85 | $4,632 |
| Fluorouracil | 27 | $1,937 |
| Ketoconazole | 107 | $1,606 |
| Azelaic Acid | 16 | $1,432 |
| Triamcinolone Acetonide | 119 | $1,189 |
| Tretinoin | 13 | $888 |
| ValacyclovirValacyclovir Hcl | 19 | $755 |
| Metronidazole | 16 | $639 |
| Nystatin | 41 | $469 |
| Doxycycline Hyclate | 21 | $355 |
| Ammonium Lactate | 16 | $331 |
| Clindamycin Phosphate | 12 | $260 |
| Mupirocin | 29 | $212 |
| Hydrocortisone | 33 | $208 |
| NyamycNystatin | 11 | $127 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Stratford
- Brett KingFairfield$6.1M
- Michael PayetteCromwell$3.4M
- Bruce StroberCromwell$3.3M
- Lisa DonofrioNew Haven$2.3M
- Mona ShahriariCromwell$2.3M
- Jeremy MossMadison$2.2M
- Brittany CraiglowFairfield$1.9M
- Meagen McCuskerEnfield$1.8M
- Christopher BunickNew Haven$1.7M
- Jun LuFarmington$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.